semaglutide trevogrumab garetosmab GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial Garetosmab (REGN2477) 10mg - Description
Pay in 4 interest-free payments of $5.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13







.png.jpg)
















